Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Wellness
Home & Realty
Outdoor Guide
Women
Class of 2023
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Services
2023 Readersâ Choice Winners
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Chimerix Inc
(NQ:
CMRX
)
0.9501
-0.0228 (-2.34%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Chimerix Inc
< Previous
1
2
3
4
5
Next >
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
September 27, 2023
The Dow Jones closed lower by around 388 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Overview Of Value Stocks In The Healthcare Sector
September 18, 2023
Via
Benzinga
Chimerix to Participate in Upcoming Investor Conferences
September 05, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
4 Analysts Have This to Say About Chimerix
August 17, 2023
Via
Benzinga
Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
August 16, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
A Look Into Healthcare Sector Value Stocks
May 22, 2023
Via
Benzinga
Chimerix Earnings Preview
May 03, 2023
Via
Benzinga
Looking Into Chimerix's Return On Capital Employed
March 08, 2023
Via
Benzinga
CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
August 11, 2023
CMRX stock may seem like a high-risk, high-potential play, but it makes sense why the market has bid down this biotech.
Via
InvestorPlace
Chimerix Reports Second Quarter 2023 Financial Results and Provides Operational Update
August 03, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Millionaire-Maker Penny Stocks to Buy Before the Window Closes
July 30, 2023
Although speculative trades are not for everyone, these millionaire-maker penny stocks could turn small bets into big returns.
Via
InvestorPlace
Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023
July 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix's Earnings Outlook
March 01, 2023
Via
Benzinga
7 Small-Cap Stocks to Buy Before the Breakout
July 27, 2023
If you don’t mind the extreme risks involved, growth investors should target these ideas for best small cap stocks to buy.
Via
InvestorPlace
Why These 7 Stocks Are the Best Ways to Play Biotech Right Now
July 11, 2023
With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.
Via
InvestorPlace
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
June 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Deeply Undervalued Growth Stocks to Buy in June
June 01, 2023
Investors may see significant rewards betting on these best undervalued growth stocks for June.
Via
InvestorPlace
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
May 31, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
May 25, 2023
Forum Aim is to Share Progress and Spur Actions to Advance the Field
From
Chimerix, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
May 23, 2023
Via
Benzinga
Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
May 04, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Report First Quarter 2023 Financial Results and Provide an Operational Update on May 4, 2023
April 27, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix Announces Presentation of Multiple Imipridone Datasets at American Association for Cancer Research Annual Meeting
April 18, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
7 Thrilling Biotech Stocks for Aggressive Investors to Buy
April 05, 2023
Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.
Via
InvestorPlace
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank
March 11, 2023
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...
Via
Benzinga
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed?
March 10, 2023
Shares of Sunrun Inc (NASDAQ: RUN), the largest residential solar developer in the U.S, fell by as much as 15% on Friday as a result of the news that Silicon Valley Bank has been closed by the
Via
Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
The biotech sector always houses a great selection of growth stocks that can grow rapidly and reward investors over the long-term.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 02, 2023
Via
Benzinga
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update
March 02, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
February 28, 2023
From
Chimerix, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.